NetworkNewsBreaks – Endonovo Therapeutics, Inc.
Post# of 7
(Total Views: 909)
Posted On: 01/27/2020 3:48:21 PM
NetworkNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Announces Initial Sales of SofPulse(R) Units to a Texas-Based VA Hospital
Endonovo Therapeutics (OTCQB: ENDV) today announced initial sales of SofPulse(R) units into a VA hospital in Texas. Endonovo’s FDA-Cleared non-invasive device for reduction of postoperative pain and edema, SofPulse(R) represents a low-cost, drug-free solution to reduce use of opioids following surgical procedures and help prevent addiction. “I am extremely proud of our team and the effort to reach such a major milestone,” Endonovo CEO Alan Collier stated in the news release. “Serving the veterans is an honor and privilege. Although the process was long and to become an approved vendor was a major accomplishment, we believe serving this VA Medical Center will open the doors for us to serve many other VA centers and assist with the VHA commitment in reducing opioid use.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Endonovo Therapeutics (OTCQB: ENDV) today announced initial sales of SofPulse(R) units into a VA hospital in Texas. Endonovo’s FDA-Cleared non-invasive device for reduction of postoperative pain and edema, SofPulse(R) represents a low-cost, drug-free solution to reduce use of opioids following surgical procedures and help prevent addiction. “I am extremely proud of our team and the effort to reach such a major milestone,” Endonovo CEO Alan Collier stated in the news release. “Serving the veterans is an honor and privilege. Although the process was long and to become an approved vendor was a major accomplishment, we believe serving this VA Medical Center will open the doors for us to serve many other VA centers and assist with the VHA commitment in reducing opioid use.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼